相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of STAT3 in skin fibrosis and transforming growth factor beta signalling
Mesias Pedroza et al.
RHEUMATOLOGY (2018)
JAK/STAT inhibitors and other small molecule cytokine antagonists for the treatment of allergic disease
Michael D. Howell et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Cucurbitacin-B attenuates CCl4-induced hepatic fibrosis in mice through inhibition of STAT-3
Alaliaa M. Sallam et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2018)
Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning
Jun Han et al.
LIPIDS IN HEALTH AND DISEASE (2018)
STAT3 controls COL1A2 enhancer activation cooperatively with JunB, regulates type I collagen synthesis posttranscriptionally, and is essential for lung myofibroblast differentiation
Ioannis Papaioannou et al.
MOLECULAR BIOLOGY OF THE CELL (2018)
Jak-TGFβ cross-talk links transient adipose tissue inflammation to beige adipogenesis
Rohollah Babaei et al.
SCIENCE SIGNALING (2018)
JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study
Javier Milara et al.
THORAX (2018)
Jak-TGFβ cross-talk links transient adipose tissue inflammation to beige adipogenesis
Rohollah Babaei et al.
SCIENCE SIGNALING (2018)
The JAK2 pathway is activated in idiopathic pulmonary fibrosis
Javier Milara et al.
RESPIRATORY RESEARCH (2018)
SAFETY AND EFFICACY OF ABT-494 (UPADACITINIB), AN ORAL JAK1 INHIBITOR, AS INDUCTION THERAPY IN PATIENTS WITH CROHN'S DISEASE: RESULTS FROM CELEST
William J. Sandborn et al.
GASTROENTEROLOGY (2017)
The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease
L. C. S. De Vries et al.
JOURNAL OF CROHNS & COLITIS (2017)
Filgotinib for Crohn's disease-expanding treatment options
Ashwin N. Ananthakrishnan
LANCET (2017)
Sav1 Loss Induces Senescence and Stat3 Activation Coinciding with Tubulointerstitial Fibrosis
Janet Y. Leung et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
Mitochondrial dysfunction induced by a SH2 domain-targeting STAT3 inhibitor leads to metabolic synthetic lethality in cancer cells
Davide Genini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis
Debomita Chakraborty et al.
NATURE COMMUNICATIONS (2017)
Sphingosine 1-Phosphate: A Novel Target for Lung Disorders
Sabira Mohammed et al.
FRONTIERS IN IMMUNOLOGY (2017)
Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling
Kristine Pettersen et al.
SCIENTIFIC REPORTS (2017)
Role of Stat3 Signaling in Control of EMT of Tubular Epithelial Cells During Renal Fibrosis
Jingsong Liu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Multifunctional Effects of a Small-Molecule STAT3 Inhibitor on NASH and Hepatocellular Carcinoma in Mice
Kwang Hwa Jung et al.
CLINICAL CANCER RESEARCH (2017)
Adipose triglyceride lipase protein abundance and translocation to the lipid droplet increase during leptin-induced lipolysis in bovine adipocytes
D. A. Kokes et al.
DOMESTIC ANIMAL ENDOCRINOLOGY (2017)
Mesenchymal Stem Cells in Fibrotic Disease
Elie El Agha et al.
CELL STEM CELL (2017)
STAT3 promotes IFNγ/TNFα-induced muscle wasting in an NF-κB-dependent and IL-6-independent manner
Jennifer F. Ma et al.
EMBO MOLECULAR MEDICINE (2017)
PPARγ Links BMP2 and TGFβ1 Pathways in Vascular Smooth Muscle Cells, Regulating Cell Proliferation and Glucose Metabolism
Laurent Calvier et al.
CELL METABOLISM (2017)
Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis
Claudio Cerchione et al.
ANNALS OF HEMATOLOGY (2017)
Mesenchymal stem cells protect against obstruction-induced renal fibrosis by decreasing STAT3 activation and STAT3-dependent MMP-9 production
Futoshi Matsui et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis
Elie El Agha et al.
CELL STEM CELL (2017)
STAT3 integrates cooperative Ras and TGF-β signals that induce Snail expression
M. Saitoh et al.
ONCOGENE (2016)
STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling
G. Wang et al.
ONCOGENE (2016)
STAT3 inhibition prevents lung inflammation, remodeling, and accumulation of Th2 and Th17 cells in a murine asthma model
A. C. Gavino et al.
ALLERGY (2016)
Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment
Yuji Miyamoto et al.
CLINICAL CANCER RESEARCH (2016)
STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation
Mesias Pedroza et al.
FASEB JOURNAL (2016)
Fyn deficiency attenuates renal fibrosis by inhibition of phospho-STAT3
Hye-Young Seo et al.
KIDNEY INTERNATIONAL (2016)
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
Dinesh Khanna et al.
LANCET (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma
Uddalak Bharadwaj et al.
ONCOTARGET (2016)
Understanding cachexia as a cancer metabolism syndrome
P. E. Porporato
ONCOGENESIS (2016)
Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years - United States, 2015
James M. Dahlhamer et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2016)
Autophagy is induced in the skeletal muscle of cachectic cancer patients
Zaira Aversa et al.
SCIENTIFIC REPORTS (2016)
STAT3 inhibition suppresses hepatic stellate cell fibrogenesis: HJC0123, a potential therapeutic agent for liver fibrosis
Omar Nunez Lopez et al.
RSC ADVANCES (2016)
Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis
Rami S. Komrokji et al.
BLOOD (2015)
Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs Survival
Amelia J. Johnston et al.
CELL (2015)
Homeostasis, Inflammation, and Disease Susceptibility
Maya E. Kotas et al.
CELL (2015)
A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis
Alessandro M. Vannucchi et al.
HAEMATOLOGICA (2015)
Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I
Srdan Verstovsek et al.
HAEMATOLOGICA (2015)
Dynamic control of Th2 cell responses by STAT3 during allergic lung inflammation in mice
Hoyong Lim et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
The sphingosine-1-phosphate/sphingosine-1-phosphate receptor 2 axis regulates early airway T-cell infiltration in murine mast cell-dependent acute allergic responses
Carole A. Oskeritzian et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Inhibition of Stat3 Activation Suppresses Caspase-3 and the Ubiquitin-Proteasome System, Leading to Preservation of Muscle Mass in Cancer Cachexia
Kleiton Augusto Santos Silva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice (vol 161, pg 4652, 1998)
K. Takeda et al.
JOURNAL OF IMMUNOLOGY (2015)
Noncanonical STAT3 Activation Regulates Excess TGF-β1 and Collagen I Expression in Muscle of Stricturing Crohn's Disease
Chao Li et al.
JOURNAL OF IMMUNOLOGY (2015)
STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease?
Paul M. Nguyen et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Muscle wasting in disease: molecular mechanisms and promising therapies
Shenhav Cohen et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma
David F. Choy et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis
Alessandro M. Vannucchi et al.
HAEMATOLOGICA (2015)
Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I
Srdan Verstovsek et al.
HAEMATOLOGICA (2015)
Crohn's disease: a clinical update
Francis Ha et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2015)
Signaling in fibrosis: TGF-beta, wNT, and YAP/TAZ converge
Bram Piersma et al.
FRONTIERS IN MEDICINE (2015)
Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis
C. Castano-Milla et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Stat3 signaling activation crosslinking of TGF-β1 in hepatic stellate cell exacerbates liver injury and fibrosis
Ming-Yi Xu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
A Noncanonical Frizzled2 Pathway Regulates Epithelial-Mesenchymal Transition and Metastasis
Taranjit S. Gujral et al.
CELL (2014)
Adipocyte-specific deficiency of Janus kinase (JAK) 2 in mice impairs lipolysis and increases body weight, and leads to insulin resistance with ageing
Sally Yu Shi et al.
DIABETOLOGIA (2014)
Diverse functions of matrix metalloproteinases during fibrosis
Matthew Giannandrea et al.
DISEASE MODELS & MECHANISMS (2014)
Interleukin-6 (IL-6) Trans Signaling Drives a STAT3-dependent Pathway That Leads to Hyperactive Transforming Growth Factor-β (TGF-β) Signaling Promoting SMAD3 Activation and Fibrosis via Gremlin Protein
Steven O'Reilly et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Signal Integration and Gene Induction by a Functionally Distinct STAT3 Phosphoform
Matthew S. Waitkus et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Stress, Inflammation, and Defense of Homeostasis
Raj Chovatiya et al.
MOLECULAR CELL (2014)
IL-10 modulates DSS-induced colitis through a macrophage-ROS-NO axis
B. Li et al.
MUCOSAL IMMUNOLOGY (2014)
IL-1α released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts
M. I. Suwara et al.
MUCOSAL IMMUNOLOGY (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
Elisabeth H. Bel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Depletion of White Adipose Tissue in Cancer Cachexia Syndrome Is Associated with Inflammatory Signaling and Disrupted Circadian Regulation
Maria Tsoli et al.
PLOS ONE (2014)
IL-6 Amplifies TLR Mediated Cytokine and Chemokine Production: Implications for the Pathogenesis of Rheumatic Inflammatory Diseases
Ivan Caiello et al.
PLOS ONE (2014)
Crohn's disease
Rahul Kalla et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014
Stephan von Haehling et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2014)
Heterogeneity in fibroblast proliferation and survival in idiopathic pulmonary fibrosis
David M. Habiel et al.
FRONTIERS IN PHARMACOLOGY (2014)
STAT3 Target Genes Relevant to Human Cancers
Richard L. Carpenter et al.
CANCERS (2014)
Cytokines in inflammatory bowel disease
Markus F. Neurath
NATURE REVIEWS IMMUNOLOGY (2014)
Autophagic Degradation Contributes to Muscle Wasting in Cancer Cachexia
Fabio Penna et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Precancerous lesions in inflammatory bowel disease
Noam Harpaz et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2013)
Strategies for anti-fibrotic therapies
Joel Rosenbloom et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Sphingosine-1-Phosphate Links Persistent STAT3 Activation, Chronic Intestinal Inflammation, and Development of Colitis-Associated Cancer
Jie Liang et al.
CANCER CELL (2013)
Stat3 Activation Links a C/EBPδ to Myostatin Pathway to Stimulate Loss of Muscle Mass
Liping Zhang et al.
CELL METABOLISM (2013)
Asthma phenotypes and endotypes
Ting-Yu Lin et al.
CURRENT OPINION IN PULMONARY MEDICINE (2013)
Targeting the JAK-STAT pathway in lymphoma: a focus on pacritinib
Enrico Derenzini et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?
Pura Munoz-Canoves et al.
FEBS JOURNAL (2013)
Epithelial to Mesenchymal Transition Promotes Breast Cancer Progression via a Fibronectin-dependent STAT3 Signaling Pathway
Nikolas Balanis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
STAT3-mediated Coincidence Detection Regulates Noncanonical Immediate Early Gene Induction
Matthew S. Waitkus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: The ENTRANCE study
K. R. Herrlinger et al.
JOURNAL OF CROHNS & COLITIS (2013)
Origin and function of myofibroblasts in kidney fibrosis
Valerie S. LeBleu et al.
NATURE MEDICINE (2013)
Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition
L. Guo et al.
ONCOGENE (2013)
Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease
Mehmet Coskun et al.
PHARMACOLOGICAL RESEARCH (2013)
IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis
Carlene L. Zindl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Therapy for Fibrotic Diseases: Nearing the Starting Line
Scott L. Friedman et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Low trypsinogen-1 expression in pediatric ulcerative colitis patients who undergo surgery
Maija Piekkala et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Modulation of the Unfolded Protein Response During Hepatocyte and Cardiomyocyte Apoptosis In Trauma/Hemorrhagic Shock
Stephen A. Thacker et al.
SCIENTIFIC REPORTS (2013)
Anti-inflammatory therapy: exploring exercise, serum-derived bovine immunoglobulin/protein isolates, and ruxolitinib for the cancer-associated weight loss syndrome
Aminah Jatoi
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2013)
IL-17 cytokines in immunity and inflammation
Wei Jin et al.
EMERGING MICROBES & INFECTIONS (2013)
JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia
Andrea Bonetto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Tyk2 and Stat3 Regulate Brown Adipose Tissue Differentiation and Obesity
Marta Derecka et al.
CELL METABOLISM (2012)
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
Ian D. Pavord et al.
LANCET (2012)
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Luke Jostins et al.
NATURE (2012)
Tofacitinib in Active Ulcerative Colitis
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer
Trevor J. Bayliss et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
New IBD genetics: common pathways with other diseases
C. W. Lees et al.
GUT (2011)
The Transcription Factor STAT3 Is Required for T Helper 2 Cell Development
Gretta L. Stritesky et al.
IMMUNITY (2011)
The novel histone deacetylase inhibitor, AR-42, inhibits gp130/Stat3 pathway and induces apoptosis and cell cycle arrest in multiple myeloma cells
Shuhong Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
IL-6 Trans-Signaling Modulates TLR4-Dependent Inflammatory Responses via STAT3
Claire J. Greenhill et al.
JOURNAL OF IMMUNOLOGY (2011)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
Carl A. Anderson et al.
NATURE GENETICS (2011)
The Regulation of Skeletal Muscle Protein Turnover during the Progression of Cancer Cachexia in the ApcMin/+ Mouse
James P. White et al.
PLOS ONE (2011)
Tissue inhibitor of metalloproteinase 1 (TIMP-1) deficiency exacerbates carbon tetrachloride-induced liver injury and fibrosis in mice: involvement of hepatocyte STAT3 in TIMP-1 production
Hua Wang et al.
CELL AND BIOSCIENCE (2011)
Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway
Yanmin Dong et al.
CARCINOGENESIS (2010)
Role of IL-21 in inflammatory bowel disease
Francesco Pallone et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2010)
Diverse Targets of the Transcription Factor STAT3 Contribute to T Cell Pathogenicity and Homeostasis
Lydia Durant et al.
IMMUNITY (2010)
The Overexpression of Heparin-Binding Epidermal Growth Factor Is Responsible for Th17-Induced Airway Remodeling in an Experimental Asthma Model
Qing Wang et al.
JOURNAL OF IMMUNOLOGY (2010)
A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy
Maoyin Pang et al.
KIDNEY INTERNATIONAL (2010)
Mice lacking the matrix metalloproteinase-9 gene reduce renal interstitial fibrosis in obstructive nephropathy
Xiaohua Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Autophagy Is Required to Maintain Muscle Mass
Eva Masiero et al.
CELL METABOLISM (2009)
Prevention of Trauma/Hemorrhagic Shock-Induced Lung Apoptosis by IL-6-Mediated Activation of Stat3
Ana Moran et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2009)
T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma
Wisam Al-Ramli et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
Geethanjali Pickert et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo
Mandy J. McGeachy et al.
NATURE IMMUNOLOGY (2009)
Transforming growth factor β as a therapeutic target in systemic sclerosis
John Varga et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
MECHANISMS OF DISEASE Inflammatory Bowel Disease
Clara Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Function of Mitochondrial Stat3 in Cellular Respiration
Joanna Wegrzyn et al.
SCIENCE (2009)
Interleukin-6 and cachexia in ApcMin/+ mice
Kristen A. Baltgalvis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice
Reiko Ito et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Anti-inflammatory activity profile of JANEX-1 in preclinical animal models
Fatih M. Uckun et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Signaling molecules: The pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer
R. Atreya et al.
CURRENT DRUG TARGETS (2008)
Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity
Erin R. Cernkovich et al.
ENDOCRINOLOGY (2008)
A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease
William J. Sandborn et al.
GASTROENTEROLOGY (2008)
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
Ken Sugimoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3
Cindy S. Ma et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice
Laura McKinley et al.
JOURNAL OF IMMUNOLOGY (2008)
Cellular and molecular mechanisms of fibrosis
T. A. Wynn
JOURNAL OF PATHOLOGY (2008)
Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
Joshua D. Milner et al.
NATURE (2008)
Colorectal cancer risk in Crohn's disease
Hugh James Freeman
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Role of cytokines in inflammatory bowel disease
Fausto Sanchez-Munoz et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
The role of matrix metalloproteinases in Stromal/Epithelial interactions in the gut
N. Sengupta et al.
PHYSIOLOGY (2007)
Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation
Zhi Chen et al.
SEMINARS IN IMMUNOLOGY (2007)
FoxO3 coordinately activates protein degradation by the Autophagic/Lysosomal and proteasomal pathways in atrophying muscle cells
Jinghui Zhao et al.
CELL METABOLISM (2007)
IL-6 signaling in inflammatory bowel disease: Pathophysiological role and clinical relevance
Jonas Mudter et al.
INFLAMMATORY BOWEL DISEASES (2007)
Unravelling the pathogenesis of inflammatory bowel disease
R. J. Xavier et al.
NATURE (2007)
The myofibroblast - One function, multiple origins
Boris Hinz et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Airway epithelial STAT3 is required for allergic inflammation in a murine model of asthma
Marina C. Simeone-Penney et al.
JOURNAL OF IMMUNOLOGY (2007)
Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology
Daniel C. Baumgart et al.
LANCET (2007)
Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies
Daniel C. Baumgart et al.
LANCET (2007)
Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice
R. Ito et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Asthma: defining of the persistent adult phenotypes
Sally E. Wenzel
LANCET (2006)
Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology
Holm H. Uhlig et al.
IMMUNITY (2006)
Critical role of IL-17 receptor signaling in acute TNBS-induced colitis
Z Zhang et al.
INFLAMMATORY BOWEL DISEASES (2006)
IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6
D Yen et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-β1 production
H Ogata et al.
ONCOGENE (2006)
Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease
KR Herllinger et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
From model to mechanism: lessons of mice and men in the discovery of protein biologicals for the treatment of inflammatory bowel disease
Janine Bilsborough et al.
EXPERT OPINION ON DRUG DISCOVERY (2006)
Interferon-β-1a for the treatment of steroid-refractory ulcerative colitis:: A randomized, double-blind, placebo-controlled trial
E Musch et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Stat3 regulates genes common to both wound healing and cancer
DJ Dauer et al.
ONCOGENE (2005)
Possible involvement of the interleukin-15 and interleukin-15 receptor system in a heightened state of lamina propria B cell activation and differentiation in patients with inflammatory bowel disease
T Nishiwaki et al.
JOURNAL OF GASTROENTEROLOGY (2005)
Signal transducers and activators of transcription 3 signaling pathway - An essential mediator of inflammatory bowel disease and other forms of intestinal inflammation
A Musso et al.
INFLAMMATORY BOWEL DISEASES (2005)
Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway
E Latres et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases
J Mudter et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
The STAT3 isoforms and have unique and specific functions
D Maritano et al.
NATURE IMMUNOLOGY (2004)
A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease
H Ito et al.
GASTROENTEROLOGY (2004)
The JAK/STAT signaling pathway
JS Rawlings et al.
JOURNAL OF CELL SCIENCE (2004)
Transcriptional inactivation of STAT3 by PPARγ suppresses IL-6-responsive multiple myeloma cells
LH Wang et al.
IMMUNITY (2004)
IKKβ/NF-κB activation causes severe muscle wasting in mice
DS Cai et al.
CELL (2004)
From symptom to diagnosis: Clinical distinctions among various forms of intestinal inflammation
BE Sands
GASTROENTEROLOGY (2004)
Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs
YP Moodley et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease
P Lovato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
STATs: Transcriptional control and biological impact
DE Levy et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Role of IL-10 for induction of anemia during inflammation
H Tilg et al.
JOURNAL OF IMMUNOLOGY (2002)
IL-15-dependent activation-induced cell death-resistant Th1 type CD8αβ+NK1.1+ T cells for the development of small intestinal inflammation
N Ohta et al.
JOURNAL OF IMMUNOLOGY (2002)
Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease
T Kanai et al.
GASTROENTEROLOGY (2001)
CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation
A Suzuki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors
T Hirano et al.
ONCOGENE (2000)
IL-6 is required for the development of Th1 cell-mediated murine colitis
M Yamamoto et al.
JOURNAL OF IMMUNOLOGY (2000)
IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production
ZJ Liu et al.
JOURNAL OF IMMUNOLOGY (2000)
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation:: Evidence in Crohn disease and experimental colitis in vivo
R Atreya et al.
NATURE MEDICINE (2000)
Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites
G Mantovani et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2000)
分享论文
